Log In
BCIQ
Print this Print this
 

Voruciclib (P1446A-05)

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
DescriptionOral cyclin dependent kinase 4 (CDK4) and CDK6 inhibitor
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/24/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today